61755-020Level 3
Praluent (alirocumab)
**Product type:** Human Prescription Drug
**Active ingredient:** ALIROCUMAB
**Strength:** 75 mg/mL
**Dosage form:** Injection, Solution
**Route:** Subcutaneous
**Labeler:** Regeneron Pharmaceuticals, Inc.
**Marketing category:** BLA (BLA125559)
**Pharmacologic class:** Antibodies, Monoclonal [CS], PCSK9 Inhibitor [EPC], PCSK9 Inhibitors [MoA]
GET
/api/v1/systems/ndc_fda/nodes/61755-020Hierarchy Explorer
Loading...
Cross-system equivalences0
No cross-system equivalences mapped for this node.